|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made
|
Luke Timmerman |
04/04/11 |
National
|
|
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond
|
Luke Timmerman |
09/15/10 |
National
|
|
Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference
|
Luke Timmerman |
09/15/10 |
Boston
|
|
VC Investment in New England Declines in Second Quarter (Two Out of Three Surveys Say); Top 10 Deals Dominated by Biotech
|
Gregory T. Huang |
07/19/10 |
Boston
|
|
Third Rock Invests in Ablexis, Acceleron Grabs $8.4M, Alnylam Chief Joins Agios Board, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/25/10 |
Boston
|
|
Massachusetts Startups Pull in $186M in May; Life Sciences Companies Take the Top Five Deals
|
Erin Kutz |
06/24/10 |
Boston
|
|
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/04/10 |
Boston
|
|
Zipcar Files for $75M IPO, Tetraphase Gets $45M, Covidien Acquires ev3 for $2.6B, & More Boston-Area Deals News
|
Erin Kutz |
06/02/10 |
Boston
|
|
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics
|
Luke Timmerman |
06/01/10 |
Boston
|
|
TetraPhase Pharmaceuticals Receives $45,000,000 Series C Financing
|
VentureDeal |
06/01/10 |
Boston
|
|
Google Backs Adimab, PVI Sweetens E Ink Deal, Sanofi-Aventis Partners With Merrimack Pharma, & More Boston-Area Deals News
|
Rebecca Zacks |
10/02/09 |
Boston
|
|
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News
|
Ryan McBride |
09/30/09 |
Boston
|
|
TetraPhase Pharmaceuticals Secures $10,000,000 New Financing
|
VentureDeal |
09/25/09 |
Boston
|
|
Follica’s Fortunes Growing, Icahn’s Biogen Holdings Mounting, Genzyme’s Mipomersen Work Progressing, & More Life Sciences News
|
Rebecca Zacks |
08/13/08 |
Boston
|
|
A123 Files For “Lucky” IPO, BP Shells out $90M for Verenium’s Biofuel Tech, Alnylam Ventures into New RNA Realm, & More Deals News
|
Rebecca Zacks |
08/11/08 |
Boston
|
|
TetraPhase Aims to Fill the Antibiotic Pipeline—and its Executive Office
|
Ken Wilan |
10/05/07 |
Boston
|
|
Boston’s New Generation of University Spinoffs
|
Rebecca Zacks |
09/06/07 |
Boston
|
|
Boston’s New Generation of University Spinoffs: The List
|
Rebecca Zacks |
09/06/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.